Subscribe for News and Updates
Stay informed with the latest news, updates, and episodes from the HeadWise podcast.
Match to clinical trials in 60 seconds
- Know your options
- Access the latest treatments
- Receive world class care
Abbvie Clinical Trials - Migraine
Adolescents:
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
https://www.abbvieclinicaltrials.com/study/?id=3110-305-002
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
https://www.abbvieclinicaltrials.com/study/?id=M21-201
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
https://www.abbvieclinicaltrials.com/study/?id=M23-712
Adults:
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
https://www.abbvieclinicaltrials.com/study/?id=M24-305
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
https://www.abbvieclinicaltrials.com/study/?id=M23-714
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
https://www.abbvieclinicaltrials.com/study/?id=M24-859
Pfizer Clinical Trials - Migraine
Adolescents:
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
https://clinicaltrials.gov/study/NCT06616194
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
https://clinicaltrials.gov/study/NCT05156398
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
https://clinicaltrials.gov/study/NCT04649242
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
https://clinicaltrials.gov/study/NCT04743141
Adults:
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
https://clinicaltrials.gov/study/NCT06641466
Lundbeck Clinical Trials - Migraine
Adolescents:
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine (PROSPECT-1)
https://clinicaltrials.gov/study/NCT05897320
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine (PROSPECT-2)
https://clinicaltrials.gov/study/NCT04965675
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (REJOIN)
https://clinicaltrials.gov/study/NCT05164172
Adults:
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (PROCEED)
https://clinicaltrials.gov/study/NCT06323928
Lilly Clinical Trials - Migraine
Adolescents:
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)
https://clinicaltrials.gov/study/NCT04616326
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)
https://clinicaltrials.gov/study/NCT04396574
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
https://clinicaltrials.gov/study/NCT04396236
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)
https://clinicaltrials.gov/study/NCT03432286
Teva Migraine Pregnancy Registry
The Teva Migraine Pregnancy Registry studies the effects of migraine medications during pregnancy. Eligible participants (ages 18-45) can join by completing a short screening. No extra medical visits required.
MRI Brain Study of Migraine
UNC-Chapel Hill School of Medicine is recruiting 201 adults (18+) from three groups (67 in each group):
- Adults with migraine taking anti-CGRP medications
- Adults with migraine who are not taking anti-CGRP medications
- Adults with no history of migraine
Enrolling now through September 2026
